Literature DB >> 30711314

Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia.

Pengfei Xu1, Nicky G Klaasen2, Esther M Opmeer3, Gerdina H M Pijnenborg4, Marie-José van Tol2, Edith J Liemburg2, André Aleman5.   

Abstract

BACKGROUND: Social amotivation is a core element of the negative symptoms of schizophrenia. However, it is still largely unknown which neural substrates underpin social amotivation in people with schizophrenia, though deficiencies in the mesocorticolimbic dopamine system have been proposed.
METHODS: We examined the association between social amotivation and substantia nigra/ventral tegmental area-seeded intrinsic connectivity in 84 people with schizophrenia using resting state functional magnetic resonance imaging.
RESULTS: Spontaneous fluctuations of midbrain dopaminergic regions were positively associated with striatal and prefrontal fluctuations in people with schizophrenia. Most importantly, social amotivation was negatively associated with functional connectivity between the midbrain's substantia nigra/ventral tegmental area and medial- and lateral prefrontal cortex, the temporoparietal junction, and dorsal and ventral striatum. These associations were observed independently of depressive and positive symptoms.
CONCLUSIONS: Our findings suggest that social amotivation in people with schizophrenia is associated with altered intrinsic connectivity of mesocorticolimbic pathways linked to cognitive control and reward processing. Dysconnectivity of dopaminergic neuronal ensembles that are fundamental to approach behavior and motivation may help explain the lack of initiative social behavior in people with social amotivation.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Mesocorticolimbic pathways; Resting state functional connectivity; Schizophrenia; Social amotivation; Ventral tegmental area

Mesh:

Substances:

Year:  2019        PMID: 30711314     DOI: 10.1016/j.schres.2019.01.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

Review 1.  Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate.

Authors:  A J Robison; Katharine N Thakkar; Vaibhav A Diwadkar
Journal:  Biol Psychiatry       Date:  2019-10-03       Impact factor: 13.382

2.  Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome.

Authors:  Ángeles Tepper; Analía Cuiza; Luz María Alliende; Carlos Mena; Juan Pablo Ramirez-Mahaluf; Barbara Iruretagoyena; Claudia Ornstein; Rosemarie Fritsch; Ruben Nachar; Alfonso González-Valderrama; Juan Undurraga; Juan Pablo Cruz; Cristian Tejos; Alex Fornito; Gabriela Repetto; Nicolas Crossley
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 9.306

3.  Differences in Functional Connectivity Networks Related to the Midbrain Dopaminergic System-Related Area in Various Psychiatric Disorders.

Authors:  Yuko Nakamura; Naohiro Okada; Daisuke Koshiyama; Kouhei Kamiya; Osamu Abe; Akira Kunimatsu; Kazuo Okanoya; Kiyoto Kasai; Shinsuke Koike
Journal:  Schizophr Bull       Date:  2020-01-05       Impact factor: 9.306

4.  Brain activity and connectivity differences in reward value discrimination during effort computation in schizophrenia.

Authors:  Clara Pretus; Daniel Bergé; Xavier Guell; Victor Pérez; Óscar Vilarroya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-03       Impact factor: 5.270

5.  Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials.

Authors:  Kah Kheng Goh; Chun-Hsin Chen; Tzu-Hua Wu; Yi-Hang Chiu; Mong-Liang Lu
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

Review 6.  Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review.

Authors:  Julia Schulz; Juliana Zimmermann; Christian Sorg; Aurore Menegaux; Felix Brandl
Journal:  Front Psychiatry       Date:  2022-09-20       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.